Safety and feasibility of a new rectoscope in rectal cancer surgery. First clinical trial

Mario Álvarez Gallego,Sara Gortázar de Las Casas,Esteban Díaz Serrano,Isabel Pascual Migueláñez
DOI: https://doi.org/10.1016/j.cireng.2024.07.005
2024-08-31
Abstract:We present a first in human clinical trial of a new rectoscope that shows, by means of transillumination, the optimal point of transection of the rectum in oncologic surgery. The device was developed together with a team of engineers and was manufactured by 3D printing. Eighteen patients with a mean age of 71 years and a mean distance from the tumor to the anal margin measured by colonoscopy of 10.4 ± 3.9 cm and by MRI of 10 ± 2.4 cm were included in the trial. Transillumination was feasible in all cases, and the use of the rectoscope was safe, as no adverse events due to its use were recorded.
What problem does this paper attempt to address?